Table 4.
Adherence to treatment
| Variable | Saudi Arabia n=206 | Turkey n=199 | Overall n=405 | p-value |
|---|---|---|---|---|
| Morisky score*, n (%) | ||||
| Count | 190 | 196 | 405 | |
| Mean (±SD) | 4.6 (±2.4) | 6.2 (±1.8) | 5.4 (±2.3) | <0.0001 |
| <6 (low) | 122 (64.2) | 68 (34.7) | 190 (49.2) | <0.0001 |
| 6 to <8 (medium) | 46 (24.2) | 73 (37.2) | 119 (30.8) | |
| =8 (high) | 22 (11.6) | 55 (28.1) | 77 (20.0) | |
Notes: Adherence to treatment for the overall study population and by country, measured using the MMAS-8. The p-values were calculated using the χ2-test for the MMAS-8 categories and the Kruskal–Wallis test for the MMAS-8 mean score.
*
The MMAS (8-item) content, names, and trademarks are protected by the US copyright and trademark laws. Permission for use of the scale and its coding is required. A license agreement is available from Donald E Morisky, ScD, ScM, MSPH,14725 NE 20th St Bellevue, WA 98007, USA; dmorisky@gmail.com.
Abbreviation: MMAS-8, 8-Item Morisky Medication Adherence Survey.